# Coronal pulpotomy in mature permanent mandibular molars with irreversible pulpitis using fast setting calcium silicate cement: a case series with 1-year follow-up

**Authors:** Vaidehi Joshi, Roopa Babannavar, T.N Nandini, Sophia Thakur, Mallikarjun Goud

PMC · DOI: 10.2340/biid.v12.44850 · Biomaterial Investigations in Dentistry · 2025-10-15

## TL;DR

This case series shows that Ultrafast Protooth, a fast-setting calcium silicate cement, can be successfully used for coronal pulpotomy in mature molars with irreversible pulpitis.

## Contribution

The study introduces Ultrafast Protooth as a novel material for coronal pulpotomy with favorable 1-year outcomes.

## Key findings

- All treated teeth remained asymptomatic with no signs of pain or infection after 1 year.
- Radiographic evaluation showed no periapical disease during the follow-up period.
- Ultrafast Protooth achieved hemostasis and set within clinically acceptable timeframes.

## Abstract

Ultrafast Protooth is a calcium silicate cement with a rapid initial setting time of 2 minutes. Its fluoride release, apatite-forming capability and favourable biocompatibility make it a potential candidate for vital pulp therapy.

This case series evaluates the coronal pulpotomy outcomes using Ultrafast Protooth in permanent molars having closed apices diagnosed with symptomatic irreversible pulpitis.

After anaesthetisation, the tooth was isolated and disinfected, and caries were excavated. Vitality was re-assessed intra-operatively based on the bleeding response. Coronal pulpotomy was performed using Ultrafast Protooth if haemostasis was achieved within the clinically accepted time. After confirming that the material had set, based on the manufacturer’s guidelines and clinical judgement, a permanent composite restoration was placed, followed by postoperative radiographs.

All teeth remained asymptomatic, showing no clinical signs of pain, inflammation, or infection and responded positively to pulp sensibility tests. Radiographs confirmed no periapical disease during the 1-year follow-up.

Ultrafast Protooth showed favourable 1-year clinical and radiographic outcomes. Continued follow-up and further controlled trials are warranted to validate these findings.

## Full-text entities

- **Diseases:** pulpitis (MESH:D011671), caries (MESH:D003731), inflammation (MESH:D007249), pain (MESH:D010146), infection (MESH:D007239), periapical disease (MESH:D010483), bleeding (MESH:D006470)
- **Chemicals:** calcium silicate (MESH:C031293), Protooth (-), fluoride (MESH:D005459)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12536650/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12536650/full.md

## References

22 references — full list in the complete paper: https://tomesphere.com/paper/PMC12536650/full.md

---
Source: https://tomesphere.com/paper/PMC12536650